Pharmaron Beijing Co., Ltd. (FRA:17Q1)

Germany · Delayed Price · Currency is EUR

2.200

-0.040 (-1.79%)

At close: Jan 28, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Laboratory Services	7.05B
Laboratory Services Growth	5.81%
Chemical and Formulation Process Development and Production Services	2.99B
Chemical and Formulation Process Development and Production Services Growth	10.24%
Clinical Research Services	1.83B
Clinical Research Services Growth	5.12%
Macromolecule and Cell and Gene Therapy Services	407.52M
Macromolecule and Cell and Gene Therapy Services Growth	-4.10%
Other	6.40M
Other Growth	38.79%
Other	6.40M
Other Growth	38.79%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Other	39.51M
Other Growth	-19.17%
North America	7.85B
North America Growth	6.11%
Europe	2.27B
Europe Growth	23.18%
China	1.85B
China Growth	-6.46%
Asia	264.27M
Asia Growth	-1.77%
Other	39.51M
Other Growth	-19.17%